openPR Logo
Press release

Global Neuropathic Pain Treatment Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026

02-23-2021 12:14 PM CET | Health & Medicine

Press release from: Orion Market Research

Global Neuropathic Pain Treatment Market Trends 2020 |

The global neuropathic pain treatment market is estimated to grow at a CAGR of nearly 5.8% during the forecast period. The demand for neurostimulation therapy for neuropathic pain management is expected to emerge owing to its significant potential in pain relief by interrupting the pain signals traveling between the brain and the spinal cord. Rising spinal cord injuries and diabetic neuropathy complications have led the demand for more potential and reliable pain management treatment, which in turn, will likely offer scope for neurostimulation therapy. As of 2019, the estimated number of individuals suffering from spinal cord injury in the US is nearly 291,000. Nearly 78% of new incidences were reported among males.

To Request a Sample of our Report on Global Neuropathic Pain Treatment Market: https://www.omrglobal.com/request-sample/neuropathic-pain-treatment-market

Neuropathic pain is the most common in patients suffering from spinal cord injury and usually difficult to treat. Spinal cord stimulation is an emerging technique that can be preferably used in interdisciplinary pain treatment. The main indications to use spinal cord stimulation include neuropathic pain conditions such as peripheral nerve injuries or complex regional pain syndrome (CRPS) or as well as mixed neuropathic conditions such as failed back surgery syndrome (FBSS). In spinal cord stimulation therapy, the electric pulses alter and mask the pain signals before they reach the brain.

It is a small device, like a pacemaker that delivers electrical pulses to the spinal cord and thereby supports people to effectively manage their chronic pain and decrease their use of opioid medications. It is considered as a safe, minimally invasive, and reversible treatment. However, further research is required to find out more evidence of the potential effects of spinal cord stimulation in neuropathy pain management, which may support to leverage the adoption of this therapy for the condition. The major companies in the field of neurostimulation include Abbott Laboratories, Boston Scientific Corp., and Medtronic plc.

These companies are focusing on developing neurostimulation devices to potentially manage neuropathic pain. For instance, in January 2017, Abbott Laboratories declared the introduction of the new Proclaim DRG neurostimulation system, which is developed to deliver dorsal root ganglion (DRG) stimulation to people with chronic neuropathic pain. The Proclaim DRG neurostimulation system delivers a more intuitive therapy experience to the patients coupled with the Proclaim platform's Bluetooth wireless technology and iOS software. The Proclaim DRG neurostimulation system targets nerves within the DRG and thus, it has been clinically demonstrated to offer better pain relief than conventional spinal cord stimulation therapy as it directly targets the area of the body where pain occurs to improve quality of life.

The approval of Proclaim DRG neurostimulation system is offering access to this platform for the patients suffering from chronic neuropathic pain. The system features magnetic resonance (MR)-conditional recharge-free system that delivers better programming, increased battery capacity, and upgradeability. It also uses an iPod touch mobile digital device patient controller that provides wireless communication through Bluetooth wireless technology. Such kinds of innovations in neurostimulation devices will increase the reliability and efficacy of these devices for neuropathic pain treatment, which in turn, is expected to drive the global neuropathic pain treatment market.

(Get 15% Discount on Buying this Report)
A full Report of Global Neuropathic Pain Treatment Market is Available at: https://www.omrglobal.com/industry-reports/neuropathic-pain-treatment-market

Global Neuropathic Pain Treatment Market- Segmentation

By Indication

• Spinal Stenosis
• Diabetic Neuropathy
• Chemotherapy-Induced Peripheral Neuropathy
• Others

By Treatment

• Tricyclic Antidepressants
• Anticonvulsants
• Opioids
• Creams and Patches
• Steroids
• Others (Neurostimulation and Local Anesthesia)

Global Neuropathic Pain Treatment Market– Segment by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa

Company Profiles

• Abbott Laboratories
• Acorda Therapeutics, Inc.
• Assertio Therapeutics, Inc.
• Astellas Pharma Inc.
• AstraZeneca plc
• Biogen Inc.
• BioIntervene, Inc.
• Boston Scientific Corp.
• Cipla Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Eli Lilly and Co.
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Ltd.
• Grünenthal GmbH
• Johnson & Johnson Services, Inc.
• Lexicon Pharmaceuticals, Inc.
• Lupin Ltd.
• Medtronic plc
• Pfizer Inc.
• Sanofi S.A.

• Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neuropathic-pain-treatment-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neuropathic Pain Treatment Market Trends 2020 | Segmentation, Outlook, Industry Report to 2026 here

News-ID: 2247075 • Views: 87

More Releases from Orion Market Research

Polyphenylsulfone Market Trends 2019 | Segmentation, Outlook, Industry Report to …
Global polyphenylsulfone (PPSU) market is projected to show an increase in the market share with the wide usage in the industries such as medical, automotive, aerospace, household/food technology, electrical/ electronic and others. In these industries, PPSU is used in devices such as hot water fittings, sanitary-plumbing, dental-surgical instruments, automotive-aircraft interior, and 3D printing devices as the material from which it is made is high heat resistant and possess excellent hydrolytic
Global Digital Assistant in Healthcare Market 2020 Analysis May Set New Growth S …
The global digital assistant in healthcare market is projected to exhibit a significant growth, at a CAGR of around 35.0%, during the forecast period. AI-based chat bots and other applications further support in providing care to an individual by offering nursing assistance facility even after discharge from the hospital. This feature aids in simplifying the facility of outpatient services along with an increase in monitoring patient compliance after discharge of
Switzerland Electric Car Market 2020 Trends, Research Report, Growth, Opportunit …
Switzerland Electric Car Market is anticipated to grow with a significant CAGR of 21% during the forecast period (2019-2025). Growing demand for zero-emission vehicles, stringent government regulations and rising charging infrastructure across the country are major factors that are expected to propel the Switzerland electric car market. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/switzerland-electric-car-market In 2018, just 2% of all passenger cars on Swiss roads were
Spain Electric Car Market 2020: By Key Players, Market Share, Forecast to 2026
Spain electric car market is anticipated to grow with a significant CAGR of 21.0% during the forecast period (2019-2025). Growing environmental concerns, rising government initiatives, and the rising demand for zero-emission vehicles are expected to drive the market. A growth of around 48% was reported on the Spain electric car market in 2019 and reached around 17,500 compared to 11,800 in 2018, as per the International Energy Agency (IEA). The

All 5 Releases


More Releases for Neuropathic

Neuropathic Pain Therapeutics Market: Competitive Dynamics & Global Outlook 2020 …
Global Info Research offers a latest published report on Neuropathic Pain Therapeutics Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Neuropathic Pain Therapeutics Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.
Neuropathic Pain Market Estimated to Flourish by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The
Neuropathic Pain Market to Perceive Substantial Growth During 2024
According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Neuropathic Pain: Anticonvulsants Drug Class Segment Projected to Witness the Highest Growth Through 2024’, the global neuropathic pain market was valued at US$ 5.2 Bn in 2015 and is estimated to reach a market valuation of US$ 5.4 Bn by 2016. The market is projected to expand at a CAGR of 5.6% during an
Neuropathic Pain Market Stood at US$ 8.3 Bn by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also